Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Cash flows from operating activities          
Net income / (loss) [1]     $ 26,661 $ 8,366  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization [1]     40,010 24,981  
Non-cash interest expense [1]     408 298  
Stock-based compensation expense [1]     12,023 9,630  
Foreign exchange transaction (gain) / loss [1]     612 0  
Change in estimate of remaining contingent consideration $ 0 [2] $ 22,087 [2] 0 [1] 22,087 [1]  
Right-of-use asset [1]     5,079 1,951  
Deferred income taxes [1]     (2,228) 178  
(Increase) / decrease in assets:          
Accounts receivable, gross [1]     9,916 (61,855)  
Allowance for credit losses [1]     2,249 (31)  
Prepaid expenses and other current assets [1]     (4,608) (4,917)  
Other non-current assets [1]     160 95  
Increase / (decrease) in liabilities:          
Accounts payable [1]     2,371 51,676  
Accrued license fees and revenue share [1]     (16,866) 1,382  
Accrued compensation [1]     (15,109) (45,694)  
Other current liabilities [1]     9,406 2,643  
Other non-current liabilities [1]     (5,775) (3,036)  
Net cash provided by operating activities [1]     64,309 7,754  
Cash flows from investing activities          
Business acquisitions, net of cash acquired [1]     0 (148,056)  
Capital expenditures [1]     (12,930) (10,411)  
Net cash used in investing activities [1]     (12,930) (158,467)  
Cash flows from financing activities          
Proceeds from borrowings [1]     0 267,134  
Payment of debt issuance costs [1]     0 (2,988)  
Options and warrants exercised [1]     939 2,155  
Payment of withholding taxes for net share settlement of equity awards [1]     (5,929) 0  
Repayment of debt obligations [1]     (86,500) (46,256)  
Net cash provided by / (used in) financing activities [1]     (91,490) 220,045  
Effect of exchange rate changes on cash and cash equivalents and restricted cash [1]     (3,838) (4,233)  
Net change in cash and cash equivalents and restricted cash [1]     (43,949) 65,099  
Cash and cash equivalents and restricted cash, beginning of period [1]     127,162 31,118 $ 31,118
Cash and cash equivalents and restricted cash, end of period [1] $ 83,213 $ 96,217 83,213 96,217 127,162
Supplemental disclosure of cash flow information          
Interest paid [1]     7,410 2,199  
Income taxes paid [1]     1,076 693  
Supplemental disclosure of non-cash activities          
Fair value of unpaid contingent consideration in connection with business acquisitions [1]     0 235,500  
Fyber          
Adjustments to reconcile net income to net cash provided by operating activities:          
Change in estimate of remaining contingent consideration         $ 50,000
Supplemental disclosure of non-cash activities          
Common stock issued for the acquisition of Fyber [1]     50,000 356,686  
Unpaid cash consideration for the acquisition of Fyber Minority Interest [1]     2,578 3,108  
AdColony          
Adjustments to reconcile net income to net cash provided by operating activities:          
Change in estimate of remaining contingent consideration       (8,913)  
Supplemental disclosure of non-cash activities          
Unpaid cash consideration for the acquisition of Fyber Minority Interest [1]     $ 0 $ 100,000  
[1] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3 in the accompanying condensed consolidated financial statements.
[2] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3 in the accompanying condensed consolidated financial statements.